Dual human epidermal growth factor receptor 2 (HER2) blockade and hormonal therapy for the treatment of primary HER2-positive breast cancer: one more step toward chemotherapy-free therapy Journal Article


Authors: Prat, A.; Baselga, J.
Article Title: Dual human epidermal growth factor receptor 2 (HER2) blockade and hormonal therapy for the treatment of primary HER2-positive breast cancer: one more step toward chemotherapy-free therapy
Keywords: note; adjuvant therapy; neoadjuvant therapy; methodology; antineoplastic agent; neoplasm recurrence, local; antineoplastic combined chemotherapy protocols; epidermal growth factor receptor 2; tumor markers, biological; breast neoplasms; tumor marker; tumor recurrence; breast tumor; receptor, erbb-2; antineoplastic agents, hormonal; antineoplastic hormone agonists and antagonists; erbb2 protein, human
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 14
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-10
Start Page: 1703
End Page: 1706
Language: English
DOI: 10.1200/jco.2012.48.4998
PUBMED: 23569319
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 25 September 2013" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga